---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-125849"
form_type: "8-K"
ticker: "BTAI"
cik: "0001720893"
company_name: "BioXcel Therapeutics, Inc."
filed_at: "2021-10-13T23:59:59+00:00"
generated_at: "2026-06-28T21:09:55.888314+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# BioXcel Therapeutics EVP & Chief Commercial Officer William P. Kane resigns effective immediately

## Summary
- William P. Kane, Jr., EVP and Chief Commercial Officer, resigned on October 8, 2021, effective immediately.
- No reason for the resignation was provided in the filing.
- No successor or interim appointment has been announced.

## SEC filing metadata
- accession: 0001104659-21-125849
- form_type: 8-K
- ticker: BTAI
- cik: 0001720893
- company_name: BioXcel Therapeutics, Inc.
- filed_at: 2021-10-13T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1720893/000110465921125849/0001104659-21-125849-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1720893/000110465921125849/tm2129371d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-125849
- JSON: https://secwatch.observer/filing/0001104659-21-125849.json
- Plain text: https://secwatch.observer/filing/0001104659-21-125849.txt

## Key facts
- Executive change
  William P. Kane, Jr. resigned as Executive Vice President and Chief Commercial Officer at BioXcel Therapeutics, Inc..
  - Action: resigned
  - Role: Executive Vice President and Chief Commercial Officer
  source text: On October 8, 2021, William P. Kane, Jr., Executive Vice President and Chief Commercial Officer of BioXcel Therapeutics, Inc. (the “Company”) tendered his resignation notice to the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1720893/000110465921125849/0001104659-21-125849-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.